Literature DB >> 2555432

Molecular pathogenesis of neural lesions induced by poliovirus type 1.

T Couderc1, C Christodoulou, H Kopecka, S Marsden, L F Taffs, R Crainic, F Horaud.   

Abstract

Using in situ hybridization techniques for viral RNA and employing a specific riboprobe, we have detected virus in neural cells of monkeys infected with poliovirus type 1 (PV-1) by the intraspinal route. In monkeys paralysed after inoculation of a neurovirulent revertant of PV-1/Sabin strain, viral RNA was detected in motor neurons and their processes, and in polymorphonuclear and small neural cells. Quantitative in situ hybridization provided evidence of viral replication in individual cells suggesting that the death of motor neurons was due to the direct effect of poliovirus replication in these cells. The histological study of neural lesions of monkeys paralysed after infection with the attenuated Sabin strain of PV-1 revealed two major differences compared to monkeys infected with a virulent strain: (i) the number of destroyed motor neurons was reduced and limited to the site of inoculation and (ii) the inflammatory reaction was localized but more intense. An account is given of the difference in histopathology induced by virulent and attenuated strains of PV-1 in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2555432     DOI: 10.1099/0022-1317-70-11-2907

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  16 in total

Review 1.  Nucleic acid detection systems for enteroviruses.

Authors:  H A Rotbart
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

Review 2.  Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Muir; U Kämmerer; K Korn; M N Mulders; T Pöyry; B Weissbrich; R Kandolf; G M Cleator; A M van Loon
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

3.  Valosin-containing protein (VCP/p97) is required for poliovirus replication and is involved in cellular protein secretion pathway in poliovirus infection.

Authors:  Minetaro Arita; Takaji Wakita; Hiroyuki Shimizu
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

4.  Poliovirus-induced apoptosis is reduced in cells expressing a mutant CD155 selected during persistent poliovirus infection in neuroblastoma cells.

Authors:  Anne-Sophie Gosselin; Yannick Simonin; Florence Guivel-Benhassine; Vincent Rincheval; Jean-Luc Vayssière; Bernard Mignotte; Florence Colbère-Garapin; Thérèse Couderc; Bruno Blondel
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

5.  Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense.

Authors:  Mathieu Pampin; Yannick Simonin; Bruno Blondel; Yann Percherancier; Mounira K Chelbi-Alix
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

6.  Mapping of mutations contributing to the temperature sensitivity of the Sabin 1 vaccine strain of poliovirus.

Authors:  M M Georgescu; M Tardy-Panit; S Guillot; R Crainic; F Delpeyroux
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

7.  Molecular pathogenesis of type 2 poliovirus in mice.

Authors:  T Couderc; B Guinguene; F Horaud; A Aubert-Combiescu; R Crainic
Journal:  Eur J Epidemiol       Date:  1989-09       Impact factor: 8.082

8.  Transgenic mice susceptible to poliovirus.

Authors:  S Koike; C Taya; T Kurata; S Abe; I Ise; H Yonekawa; A Nomoto
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

9.  A second gene for the African green monkey poliovirus receptor that has no putative N-glycosylation site in the functional N-terminal immunoglobulin-like domain.

Authors:  S Koike; I Ise; Y Sato; H Yonekawa; O Gotoh; A Nomoto
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

10.  A mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice.

Authors:  M Tardy-Panit; B Blondel; A Martin; F Tekaia; F Horaud; F Delpeyroux
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.